A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response
Saved in:
Main Authors: | Bing Feng, Li Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.70154 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A new paradigm for cancer immunotherapy: targeting immunogenic cell death-related noncoding RNA
by: Guojuan Sun, et al.
Published: (2025-01-01) -
Editorial: Community series in adenosine pathways in cancer immunity and immunotherapy, volume II
by: Junjiang Fu, et al.
Published: (2025-01-01) -
The Immune Landscape and Its Potential for Immunotherapy in Advanced Biliary Tract Cancer
by: Andry Santoso, et al.
Published: (2024-12-01) -
Pre-immunotherapy alters stereotactic ablative radiotherapy-induced systemic T cell responses in early-stage NSCLC
by: Chao Liu, et al.
Published: (2025-02-01) -
Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
by: Wu Helena T., et al.
Published: (2025-01-01)